Subcutaneous Administration of Otelixizumab is Limited by Injection Site Reactions: Results of an Exploratory Study in Type 1 Diabetes Mellitus Patients.
Experimental and Clinical Endocrinology & Diabetes（2016）
关键词
cytokine release,safety,pharmacokinetics,pharmacodynamics,anti-CD3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要